跳至主要内容
临床试验/IRCT20181022041406N1
IRCT20181022041406N1已完成未知

Catheter directed thrombolysis versus anticoagulation only in patients with Intermediate-high risk pulmonary emboli-A randomized clinical trial

Rajaie Cardiovascular Medical and Research Center0 个研究点目标入组 288 人开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
288

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 no limit(—)
性别
All

入选标准

  • Men and women = 18 year-old
  • Acute pulmonary emboli must be confirmed with pulmonary CT angiography
  • Symptoms onset = 14 days
  • Elevated pro b-type natriuretic peptide and cardiac troponin
  • Right ventricle/left ventricle ratio in pulmonary CT angiography >0.9
  • simplified pulmonary embolism severity index score >=1
  • Less than 48 hours of anticoagulation therapy

排除标准

  • Pulmonary emboli diagnosed with other modalities than pulmonary CT angiography
  • High risk (massive) pulmonary Emboli
  • Segmental pulmonary emboli
  • Patient with terminal illness
  • Surgery within 2 weeks
  • Severe renal dysfunction (creatinine clearance [CrCl] below 30 mL/min)
  • Platelet count <50.000
  • Thrombolytic contraindication
  • Concomitant right heart thrombosis
  • Pre and post catheter directed thrombolysis echocardiography exam not possible

研究者

发起方
Rajaie Cardiovascular Medical and Research Center

相似试验